SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-111155
Filing Date
2022-04-20
Accepted
2022-04-20 16:27:10
Documents
16
Period of Report
2022-04-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d339398d8k.htm   iXBRL 8-K 45469
2 EX-10.1 d339398dex101.htm EX-10.1 1405217
3 EX-99.1 d339398dex991.htm EX-99.1 11115
8 GRAPHIC g339398g0420075748995.jpg GRAPHIC 3941
  Complete submission text file 0001193125-22-111155.txt   2001899

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA prgo-20220420.xsd EX-101.SCH 5145
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE prgo-20220420_def.xml EX-101.DEF 15459
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE prgo-20220420_lab.xml EX-101.LAB 26215
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prgo-20220420_pre.xml EX-101.PRE 16746
10 EXTRACTED XBRL INSTANCE DOCUMENT d339398d8k_htm.xml XML 10726
Mailing Address 515 EASTERN AVENUE ALLEGAN MI 49010
Business Address THE SHARP BUILDING HOGAN PLACE DUBLIN 2 L2 D02 TY74 269-673-8451
PERRIGO Co plc (Filer) CIK: 0001585364 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36353 | Film No.: 22838385
SIC: 2834 Pharmaceutical Preparations